Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rfx2
|
ENSMUSG00000024206.8 | regulatory factor X, 2 (influences HLA class II expression) |
Rfx7
|
ENSMUSG00000037674.9 | regulatory factor X, 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_56814701_56814893 | Rfx2 | 16142 | 0.113267 | 0.91 | 3.9e-22 | Click! |
chr17_56814920_56815123 | Rfx2 | 15918 | 0.113636 | 0.89 | 1.3e-19 | Click! |
chr17_56814415_56814603 | Rfx2 | 16430 | 0.112792 | 0.86 | 6.3e-17 | Click! |
chr17_56815137_56815325 | Rfx2 | 15708 | 0.113980 | 0.84 | 1.1e-15 | Click! |
chr17_56813788_56814164 | Rfx2 | 16963 | 0.111908 | 0.82 | 2.9e-14 | Click! |
chr9_72532329_72532872 | Rfx7 | 9 | 0.919600 | 0.61 | 7.5e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_55205168_55205319 | 134.51 |
Dhrs2 |
dehydrogenase/reductase member 2 |
16764 |
0.11 |
chr17_85776941_85777135 | 91.20 |
Gm29418 |
predicted gene 29418 |
47006 |
0.14 |
chr9_108587464_108588439 | 87.77 |
Gm49209 |
predicted gene, 49209 |
899 |
0.26 |
chr14_123513463_123513659 | 86.30 |
Nalcn |
sodium leak channel, non-selective |
113315 |
0.06 |
chr10_79654915_79655363 | 81.64 |
Odf3l2 |
outer dense fiber of sperm tails 3-like 2 |
9401 |
0.07 |
chrX_72895479_72896098 | 81.17 |
Cetn2 |
centrin 2 |
21068 |
0.13 |
chr11_20987831_20988009 | 78.38 |
Gm23681 |
predicted gene, 23681 |
50219 |
0.13 |
chr16_39303128_39303316 | 78.21 |
Gm36742 |
predicted gene, 36742 |
114316 |
0.06 |
chr14_55149158_55149326 | 77.16 |
Gm23596 |
predicted gene, 23596 |
12366 |
0.09 |
chr10_75684046_75684480 | 74.31 |
Cabin1 |
calcineurin binding protein 1 |
16112 |
0.12 |
chr7_34570196_34571084 | 73.69 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr10_53006603_53006754 | 73.42 |
Gm47622 |
predicted gene, 47622 |
95865 |
0.07 |
chrX_103744635_103745105 | 73.22 |
Slc16a2 |
solute carrier family 16 (monocarboxylic acid transporters), member 2 |
10681 |
0.12 |
chr13_59040994_59041159 | 71.41 |
Gm34245 |
predicted gene, 34245 |
37220 |
0.14 |
chr11_35856666_35857239 | 70.23 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
3398 |
0.24 |
chr4_25408601_25409020 | 69.86 |
Gm11894 |
predicted gene 11894 |
10539 |
0.22 |
chr15_102788951_102789137 | 67.48 |
Gm49473 |
predicted gene, 49473 |
6327 |
0.16 |
chr2_181713715_181714056 | 65.14 |
Oprl1 |
opioid receptor-like 1 |
1131 |
0.32 |
chr2_66178208_66178542 | 64.67 |
Gm13618 |
predicted gene 13618 |
9461 |
0.18 |
chr16_34386621_34386847 | 63.95 |
Kalrn |
kalirin, RhoGEF kinase |
5375 |
0.34 |
chr7_6435396_6435733 | 62.74 |
Olfr1344 |
olfactory receptor 1344 |
3124 |
0.1 |
chr3_135313830_135313982 | 59.26 |
Slc9b2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
6161 |
0.16 |
chr12_29871996_29872873 | 58.44 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr2_17670178_17670376 | 58.26 |
Nebl |
nebulette |
60766 |
0.13 |
chr4_99459523_99459887 | 57.91 |
Gm12684 |
predicted gene 12684 |
28451 |
0.13 |
chr7_25068816_25069011 | 57.76 |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
3188 |
0.15 |
chr4_129960210_129960611 | 57.74 |
1700003M07Rik |
RIKEN cDNA 1700003M07 gene |
36 |
0.96 |
chr2_161148200_161148379 | 57.71 |
Gm14243 |
predicted gene 14243 |
30775 |
0.14 |
chr8_94551460_94552090 | 56.40 |
Cpne2 |
copine II |
3739 |
0.16 |
chr1_25033779_25033975 | 55.96 |
Gm29414 |
predicted gene 29414 |
6645 |
0.21 |
chr10_100865613_100865813 | 55.89 |
Gm35722 |
predicted gene, 35722 |
124078 |
0.05 |
chr5_150905805_150906370 | 54.69 |
Gm43298 |
predicted gene 43298 |
23445 |
0.17 |
chr5_137734345_137734665 | 53.43 |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
5213 |
0.09 |
chr8_71719814_71720517 | 52.92 |
Fcho1 |
FCH domain only 1 |
1142 |
0.3 |
chr13_84285225_84285539 | 52.60 |
Gm46432 |
predicted gene, 46432 |
3566 |
0.21 |
chr17_67500202_67500372 | 52.25 |
Gm36201 |
predicted gene, 36201 |
129045 |
0.05 |
chrX_94543083_94543847 | 51.85 |
Maged1 |
melanoma antigen, family D, 1 |
1322 |
0.33 |
chr9_50245051_50245269 | 51.64 |
2310003N18Rik |
RIKEN cDNA 2310003N18 gene |
11978 |
0.19 |
chr9_52146293_52146503 | 51.56 |
Zc3h12c |
zinc finger CCCH type containing 12C |
21713 |
0.17 |
chr16_34386368_34386571 | 51.56 |
Kalrn |
kalirin, RhoGEF kinase |
5640 |
0.34 |
chr17_66325723_66325912 | 51.52 |
Gm49933 |
predicted gene, 49933 |
6305 |
0.19 |
chr8_114109511_114109662 | 51.49 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
23971 |
0.25 |
chr3_17620013_17620204 | 50.99 |
Gm38154 |
predicted gene, 38154 |
50580 |
0.17 |
chrX_105392310_105392478 | 50.93 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
618 |
0.71 |
chr16_91962945_91963627 | 50.65 |
Gm27773 |
predicted gene, 27773 |
19138 |
0.1 |
chr5_9726061_9726270 | 50.39 |
Grm3 |
glutamate receptor, metabotropic 3 |
995 |
0.6 |
chr10_87447758_87448124 | 50.09 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
45719 |
0.13 |
chr4_88211578_88211756 | 49.87 |
Gm12645 |
predicted gene 12645 |
59971 |
0.11 |
chr9_39634045_39634196 | 49.79 |
Olfr961 |
olfactory receptor 961 |
10965 |
0.08 |
chr2_65415098_65415296 | 49.74 |
Gm24138 |
predicted gene, 24138 |
38915 |
0.13 |
chrX_94508060_94508408 | 48.95 |
Maged1 |
melanoma antigen, family D, 1 |
29330 |
0.1 |
chr18_66123896_66124047 | 48.73 |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
47568 |
0.11 |
chrX_72788888_72789096 | 48.63 |
Gabrq |
gamma-aminobutyric acid (GABA) A receptor, subunit theta |
36186 |
0.15 |
chr3_108961253_108961537 | 48.23 |
Henmt1 |
HEN1 methyltransferase homolog 1 (Arabidopsis) |
20084 |
0.12 |
chr7_59027544_59027695 | 47.97 |
Gm9375 |
predicted gene 9375 |
57382 |
0.07 |
chr14_52003889_52004971 | 47.87 |
Arhgef40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
58 |
0.93 |
chr8_54509471_54509955 | 47.62 |
Gm45553 |
predicted gene 45553 |
4437 |
0.21 |
chr13_99940708_99940880 | 47.56 |
Mccc2 |
methylcrotonoyl-Coenzyme A carboxylase 2 (beta) |
20256 |
0.2 |
chr9_47910509_47910693 | 47.44 |
Gm47213 |
predicted gene, 47213 |
37560 |
0.16 |
chr1_164362131_164362282 | 47.41 |
Nme7 |
NME/NM23 family member 7 |
11063 |
0.17 |
chr6_114217137_114217361 | 46.25 |
Gm8132 |
predicted gene 8132 |
47726 |
0.13 |
chr7_3684248_3684455 | 46.15 |
Mboat7 |
membrane bound O-acyltransferase domain containing 7 |
177 |
0.85 |
chr15_74902314_74902483 | 46.14 |
Ly6m |
lymphocyte antigen 6 complex, locus M |
5377 |
0.11 |
chr9_121690165_121690773 | 45.99 |
Sec22c |
SEC22 homolog C, vesicle trafficking protein |
4 |
0.96 |
chr14_66260635_66260808 | 45.90 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
20261 |
0.16 |
chr6_142876588_142876884 | 45.75 |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
6304 |
0.21 |
chr1_17838506_17838690 | 45.57 |
Gm28153 |
predicted gene 28153 |
33181 |
0.18 |
chr10_81253157_81253376 | 45.43 |
Matk |
megakaryocyte-associated tyrosine kinase |
331 |
0.69 |
chr3_32060338_32060513 | 45.22 |
Kcnmb2 |
potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
95689 |
0.08 |
chr1_179326733_179326896 | 45.16 |
Smyd3 |
SET and MYND domain containing 3 |
47289 |
0.18 |
chr13_48498020_48498213 | 44.99 |
Zfp169 |
zinc finger protein 169 |
8823 |
0.11 |
chr10_93275484_93275699 | 44.52 |
Elk3 |
ELK3, member of ETS oncogene family |
35220 |
0.13 |
chr7_16959475_16959821 | 44.29 |
Pnmal1 |
PNMA-like 1 |
31 |
0.95 |
chr15_10011651_10011840 | 44.23 |
Prlr |
prolactin receptor |
165493 |
0.04 |
chr1_42704519_42704707 | 44.20 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
3439 |
0.17 |
chr5_112843973_112844148 | 44.15 |
Myo18b |
myosin XVIIIb |
27526 |
0.17 |
chr12_116709666_116709817 | 43.88 |
Gm17807 |
predicted gene, 17807 |
112488 |
0.06 |
chr6_22716308_22716477 | 43.59 |
Gm8927 |
predicted gene 8927 |
12956 |
0.16 |
chr15_27224035_27224186 | 42.68 |
Gm19111 |
predicted gene, 19111 |
143829 |
0.04 |
chr11_32087496_32088333 | 42.30 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr18_25545971_25546175 | 42.22 |
Celf4 |
CUGBP, Elav-like family member 4 |
44834 |
0.17 |
chr3_55284304_55284525 | 42.15 |
Gm25132 |
predicted gene, 25132 |
20903 |
0.16 |
chr7_4922451_4922937 | 42.14 |
Nat14 |
N-acetyltransferase 14 |
88 |
0.91 |
chr14_75235954_75236330 | 41.94 |
Cpb2 |
carboxypeptidase B2 (plasma) |
6145 |
0.15 |
chr2_4099553_4099756 | 41.84 |
Gm38085 |
predicted gene, 38085 |
4223 |
0.14 |
chr13_78162020_78162477 | 41.77 |
3110006O06Rik |
RIKEN cDNA 3110006O06 gene |
9382 |
0.14 |
chr11_56247117_56247326 | 41.75 |
Gm12240 |
predicted gene 12240 |
15862 |
0.23 |
chr9_14634263_14634447 | 41.66 |
Amotl1 |
angiomotin-like 1 |
9174 |
0.11 |
chr10_69500300_69500451 | 41.49 |
Ank3 |
ankyrin 3, epithelial |
33397 |
0.18 |
chr9_62783122_62783568 | 41.19 |
Gm7653 |
predicted gene 7653 |
6559 |
0.18 |
chr18_31449249_31449400 | 41.08 |
Syt4 |
synaptotagmin IV |
1918 |
0.29 |
chr6_142112069_142112353 | 41.06 |
Gm18159 |
predicted gene, 18159 |
1755 |
0.36 |
chr11_30471762_30471992 | 41.06 |
4930505A04Rik |
RIKEN cDNA 4930505A04 gene |
50 |
0.98 |
chr13_59145653_59145960 | 41.03 |
Gm34307 |
predicted gene, 34307 |
22 |
0.53 |
chr3_8310829_8311058 | 40.99 |
Gm5841 |
predicted gene 5841 |
16588 |
0.25 |
chr1_80630615_80630766 | 40.77 |
Dock10 |
dedicator of cytokinesis 10 |
34585 |
0.16 |
chr3_121700295_121700994 | 40.50 |
Gm43608 |
predicted gene 43608 |
9602 |
0.11 |
chr7_117139548_117139765 | 40.43 |
Gm39075 |
predicted gene, 39075 |
89951 |
0.09 |
chr3_18764779_18764949 | 40.23 |
Gm30341 |
predicted gene, 30341 |
11787 |
0.28 |
chr12_33394846_33395166 | 40.03 |
Efcab10 |
EF-hand calcium binding domain 10 |
152 |
0.62 |
chr6_137252172_137252972 | 39.76 |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
107 |
0.98 |
chr2_4437003_4437281 | 39.74 |
Gm13175 |
predicted gene 13175 |
29528 |
0.16 |
chr4_22971277_22971442 | 39.65 |
1700025O08Rik |
RIKEN cDNA 1700025O08 gene |
32924 |
0.24 |
chr16_37938714_37939016 | 39.63 |
Gpr156 |
G protein-coupled receptor 156 |
22369 |
0.15 |
chr2_92920841_92921005 | 39.38 |
Syt13 |
synaptotagmin XIII |
5825 |
0.2 |
chr10_69465650_69465829 | 39.10 |
Gm18636 |
predicted gene, 18636 |
41991 |
0.15 |
chr7_120552900_120553073 | 39.06 |
Gm16475 |
predicted pseudogene 16475 |
170 |
0.94 |
chr3_20986381_20986745 | 38.89 |
Gm7488 |
predicted gene 7488 |
63002 |
0.13 |
chr3_119588944_119589097 | 38.87 |
Gm23432 |
predicted gene, 23432 |
49854 |
0.16 |
chr18_76011197_76011612 | 38.42 |
1700003O11Rik |
RIKEN cDNA 1700003O11 gene |
4273 |
0.28 |
chr10_92163091_92163285 | 38.06 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
48 |
0.98 |
chr11_12415334_12415643 | 38.02 |
Cobl |
cordon-bleu WH2 repeat |
3344 |
0.36 |
chr2_17703232_17703396 | 37.93 |
Nebl |
nebulette |
27729 |
0.22 |
chr12_48284505_48284715 | 37.89 |
Gm48587 |
predicted gene, 48587 |
210609 |
0.02 |
chrX_12392204_12392355 | 37.73 |
Gm14635 |
predicted gene 14635 |
37283 |
0.18 |
chr1_37220253_37220450 | 37.61 |
Cnga3 |
cyclic nucleotide gated channel alpha 3 |
1146 |
0.49 |
chr13_97900436_97900712 | 37.39 |
Gm34388 |
predicted gene, 34388 |
23912 |
0.18 |
chr4_123014550_123014728 | 37.32 |
Trit1 |
tRNA isopentenyltransferase 1 |
1958 |
0.26 |
chr15_63769035_63769240 | 37.19 |
Gm46499 |
predicted gene, 46499 |
8976 |
0.12 |
chr10_46718374_46718662 | 37.09 |
Gm19994 |
predicted gene, 19994 |
48374 |
0.16 |
chr6_51592327_51592791 | 37.04 |
Gm22914 |
predicted gene, 22914 |
29073 |
0.18 |
chr11_56753809_56753998 | 37.04 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
257484 |
0.02 |
chr13_73704941_73705129 | 37.03 |
Slc6a19 |
solute carrier family 6 (neurotransmitter transporter), member 19 |
170 |
0.91 |
chr2_66580146_66580297 | 37.00 |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
37046 |
0.17 |
chr1_46425271_46425586 | 36.99 |
Dnah7c |
dynein, axonemal, heavy chain 7C |
164 |
0.96 |
chr5_66757535_66757731 | 36.86 |
Limch1 |
LIM and calponin homology domains 1 |
11744 |
0.18 |
chr1_167608265_167608743 | 36.72 |
Rxrg |
retinoid X receptor gamma |
9805 |
0.27 |
chr3_107188579_107188812 | 36.59 |
Kcna10 |
potassium voltage-gated channel, shaker-related subfamily, member 10 |
5551 |
0.17 |
chr1_25166129_25166306 | 36.29 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
38506 |
0.14 |
chr13_65258166_65258818 | 36.12 |
Gm10775 |
predicted gene 10775 |
1047 |
0.28 |
chr2_27573150_27573355 | 36.03 |
Gm13421 |
predicted gene 13421 |
32823 |
0.13 |
chr9_24909195_24909404 | 35.99 |
Gm48255 |
predicted gene, 48255 |
43674 |
0.11 |
chr9_46389810_46389981 | 35.96 |
Gm47141 |
predicted gene, 47141 |
7467 |
0.16 |
chr9_124267973_124268128 | 35.95 |
Gm39469 |
predicted gene, 39469 |
14089 |
0.17 |
chr13_51568764_51569283 | 35.93 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
396 |
0.88 |
chr10_94230558_94231022 | 35.80 |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
31753 |
0.13 |
chr4_102855370_102855561 | 35.68 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
15099 |
0.24 |
chrX_143906539_143906984 | 35.63 |
Dcx |
doublecortin |
26289 |
0.21 |
chr17_87331968_87332159 | 35.62 |
Gm15978 |
predicted gene 15978 |
11 |
0.96 |
chr3_135610369_135610520 | 35.61 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
1961 |
0.32 |
chr5_38151396_38151547 | 35.51 |
Nsg1 |
neuron specific gene family member 1 |
7560 |
0.16 |
chr2_158561520_158561699 | 35.50 |
Arhgap40 |
Rho GTPase activating protein 40 |
19872 |
0.12 |
chr8_14447461_14447612 | 35.49 |
Dlgap2 |
DLG associated protein 2 |
65540 |
0.12 |
chr8_34472914_34473069 | 35.45 |
Gm45349 |
predicted gene 45349 |
4 |
0.98 |
chr17_35415423_35415574 | 35.35 |
H2-Q6 |
histocompatibility 2, Q region locus 6 |
9352 |
0.07 |
chr16_45690308_45690465 | 35.25 |
Tmprss7 |
transmembrane serine protease 7 |
771 |
0.57 |
chr8_112098282_112098504 | 35.24 |
Gm22827 |
predicted gene, 22827 |
35888 |
0.16 |
chr12_112329653_112329998 | 35.22 |
Gm38123 |
predicted gene, 38123 |
20242 |
0.18 |
chr5_15850216_15850406 | 35.17 |
Gm42453 |
predicted gene 42453 |
19936 |
0.14 |
chr9_51441856_51442026 | 35.12 |
1810046K07Rik |
RIKEN cDNA 1810046K07 gene |
113017 |
0.06 |
chr13_58544109_58544294 | 35.10 |
Gm3131 |
predicted gene 3131 |
1827 |
0.34 |
chr9_44457408_44457744 | 35.10 |
Upk2 |
uroplakin 2 |
2600 |
0.09 |
chr8_70791948_70793334 | 34.86 |
Mast3 |
microtubule associated serine/threonine kinase 3 |
204 |
0.83 |
chr6_108335557_108335727 | 34.73 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
20612 |
0.24 |
chr8_93569756_93570135 | 34.70 |
Gm45708 |
predicted gene 45708 |
5498 |
0.21 |
chr9_50301807_50301958 | 34.65 |
Gm39336 |
predicted gene, 39336 |
65 |
0.98 |
chr12_86942170_86942348 | 34.64 |
Cipc |
CLOCK interacting protein, circadian |
4784 |
0.19 |
chr5_34288113_34288876 | 34.49 |
Zfyve28 |
zinc finger, FYVE domain containing 28 |
45 |
0.57 |
chr11_36109551_36109767 | 34.45 |
Gm12126 |
predicted gene 12126 |
28995 |
0.23 |
chr9_111351736_111351887 | 34.29 |
Trank1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
23009 |
0.17 |
chr2_48424029_48424440 | 34.18 |
Gm13481 |
predicted gene 13481 |
33011 |
0.17 |
chr1_13188528_13188714 | 34.13 |
Gm38376 |
predicted gene, 38376 |
8907 |
0.16 |
chr3_40094252_40094403 | 34.12 |
Gm42785 |
predicted gene 42785 |
270750 |
0.01 |
chr9_59072588_59072776 | 34.08 |
Neo1 |
neogenin |
36241 |
0.18 |
chr1_85928399_85928694 | 34.06 |
4933407L21Rik |
RIKEN cDNA 4933407L21 gene |
63 |
0.96 |
chr13_18824844_18824995 | 34.04 |
Vps41 |
VPS41 HOPS complex subunit |
1124 |
0.6 |
chr1_128472535_128472770 | 33.88 |
Gm23902 |
predicted gene, 23902 |
17388 |
0.13 |
chr11_20650027_20650303 | 33.87 |
Sertad2 |
SERTA domain containing 2 |
3010 |
0.28 |
chr10_94621478_94622295 | 33.85 |
Gm48657 |
predicted gene, 48657 |
1346 |
0.34 |
chr19_24345766_24345917 | 33.79 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
28499 |
0.16 |
chr8_47284778_47285157 | 33.72 |
Stox2 |
storkhead box 2 |
4395 |
0.28 |
chr5_113591845_113592239 | 33.68 |
Wscd2 |
WSC domain containing 2 |
13254 |
0.18 |
chrX_153476799_153476977 | 33.61 |
Ubqln2 |
ubiquilin 2 |
21339 |
0.17 |
chr7_27339599_27339804 | 33.59 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
2009 |
0.19 |
chr3_83098548_83099077 | 33.53 |
Dchs2 |
dachsous cadherin related 2 |
29136 |
0.13 |
chr9_23127752_23127909 | 33.46 |
Bmper |
BMP-binding endothelial regulator |
95246 |
0.09 |
chr1_53706685_53707110 | 33.42 |
Dnah7a |
dynein, axonemal, heavy chain 7A |
113 |
0.97 |
chr6_94464427_94464624 | 33.41 |
Gm44315 |
predicted gene, 44315 |
19873 |
0.18 |
chr10_105926928_105927112 | 33.34 |
Gm24237 |
predicted gene, 24237 |
2723 |
0.32 |
chr13_13783865_13785053 | 33.28 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
130 |
0.96 |
chr6_83185947_83186166 | 33.19 |
Dctn1 |
dynactin 1 |
110 |
0.92 |
chr8_127774803_127774967 | 32.98 |
Gm22968 |
predicted gene, 22968 |
177179 |
0.03 |
chrX_100742045_100742224 | 32.81 |
Gm14902 |
predicted gene 14902 |
1041 |
0.34 |
chr5_149489128_149489325 | 32.78 |
Gm2566 |
predicted gene 2566 |
13826 |
0.12 |
chr2_165177091_165177242 | 32.77 |
Cdh22 |
cadherin 22 |
4293 |
0.2 |
chr17_75696226_75696377 | 32.77 |
Gm9360 |
predicted gene 9360 |
35061 |
0.22 |
chrX_136094566_136094717 | 32.66 |
Nxf3 |
nuclear RNA export factor 3 |
9386 |
0.12 |
chr8_106727334_106727526 | 32.54 |
Tango6 |
transport and golgi organization 6 |
44284 |
0.14 |
chr4_42946778_42947086 | 32.52 |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
2882 |
0.16 |
chr13_41416055_41416367 | 32.33 |
Gm48570 |
predicted gene, 48570 |
13920 |
0.15 |
chr5_27261861_27262062 | 32.31 |
Dpp6 |
dipeptidylpeptidase 6 |
14 |
0.98 |
chr8_95549977_95550167 | 32.27 |
1700112L15Rik |
RIKEN cDNA 1700112L15 gene |
1721 |
0.22 |
chr5_135832839_135832990 | 32.08 |
Gm23268 |
predicted gene, 23268 |
4458 |
0.12 |
chr7_96643985_96644174 | 31.95 |
Tenm4 |
teneurin transmembrane protein 4 |
93 |
0.98 |
chr5_15985978_15986202 | 31.94 |
Gm43000 |
predicted gene 43000 |
11749 |
0.19 |
chr7_16299348_16300107 | 31.76 |
Bbc3 |
BCL2 binding component 3 |
8666 |
0.11 |
chr2_13177815_13177978 | 31.65 |
Gm37780 |
predicted gene, 37780 |
14273 |
0.2 |
chr15_92975054_92975205 | 31.46 |
Gm18815 |
predicted gene, 18815 |
6314 |
0.22 |
chr7_19176285_19176869 | 31.39 |
Eml2 |
echinoderm microtubule associated protein like 2 |
156 |
0.88 |
chr3_107834158_107834338 | 31.36 |
Gm36211 |
predicted gene, 36211 |
709 |
0.52 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.1 | 54.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
16.0 | 48.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
11.0 | 33.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
10.9 | 32.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
10.5 | 42.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
9.8 | 29.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
8.9 | 35.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
8.6 | 17.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
8.1 | 48.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
7.9 | 23.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
7.7 | 31.0 | GO:0007412 | axon target recognition(GO:0007412) |
7.2 | 42.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
7.1 | 35.4 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
6.9 | 20.8 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
6.9 | 20.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
6.9 | 20.7 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
6.6 | 26.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
6.5 | 78.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
6.3 | 18.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
6.2 | 18.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
6.1 | 18.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
6.0 | 12.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
5.9 | 82.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
5.9 | 17.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
5.8 | 17.5 | GO:0014016 | neuroblast differentiation(GO:0014016) |
5.7 | 17.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
5.6 | 55.9 | GO:0071625 | vocalization behavior(GO:0071625) |
5.3 | 15.9 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
5.2 | 25.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
5.1 | 20.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
5.0 | 20.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
5.0 | 44.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
4.9 | 24.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
4.8 | 24.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
4.8 | 9.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
4.8 | 28.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
4.7 | 4.7 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
4.7 | 23.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
4.5 | 26.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
4.4 | 34.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
4.3 | 52.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
4.3 | 12.9 | GO:0030242 | pexophagy(GO:0030242) |
4.3 | 12.8 | GO:1903416 | response to glycoside(GO:1903416) |
4.1 | 45.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
3.9 | 11.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
3.8 | 7.7 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
3.8 | 26.8 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
3.8 | 18.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.7 | 11.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
3.7 | 18.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
3.7 | 11.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
3.7 | 14.7 | GO:0030035 | microspike assembly(GO:0030035) |
3.7 | 18.4 | GO:0014028 | notochord formation(GO:0014028) |
3.6 | 10.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.6 | 21.8 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
3.6 | 7.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
3.6 | 10.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
3.6 | 10.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
3.5 | 10.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
3.5 | 13.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
3.4 | 75.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
3.4 | 13.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
3.4 | 43.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
3.4 | 10.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
3.3 | 13.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.3 | 10.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
3.3 | 13.2 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
3.3 | 13.1 | GO:0021764 | amygdala development(GO:0021764) |
3.3 | 16.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.2 | 9.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
3.2 | 9.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
3.2 | 6.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.1 | 15.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
3.1 | 9.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.1 | 30.6 | GO:0022038 | corpus callosum development(GO:0022038) |
3.0 | 12.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
3.0 | 24.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
3.0 | 9.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
3.0 | 9.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
3.0 | 11.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
2.9 | 11.8 | GO:0001927 | exocyst assembly(GO:0001927) |
2.9 | 20.6 | GO:0006108 | malate metabolic process(GO:0006108) |
2.9 | 23.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
2.9 | 11.7 | GO:0021554 | optic nerve development(GO:0021554) |
2.9 | 14.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.8 | 8.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.8 | 2.8 | GO:0097107 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
2.8 | 13.9 | GO:0090148 | membrane fission(GO:0090148) |
2.7 | 8.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.7 | 5.5 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.7 | 8.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.7 | 13.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
2.7 | 13.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.7 | 5.4 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
2.7 | 2.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
2.6 | 7.9 | GO:0098597 | observational learning(GO:0098597) |
2.6 | 13.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
2.6 | 7.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.6 | 5.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
2.6 | 7.9 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.6 | 33.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.6 | 5.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
2.6 | 10.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.5 | 7.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.5 | 5.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.5 | 10.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
2.5 | 5.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.5 | 19.9 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
2.5 | 7.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.5 | 22.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.5 | 2.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.4 | 2.4 | GO:0051795 | positive regulation of catagen(GO:0051795) |
2.4 | 4.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
2.4 | 7.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
2.4 | 16.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.4 | 12.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.4 | 7.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.4 | 7.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.4 | 42.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.3 | 7.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
2.3 | 7.0 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.3 | 2.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
2.3 | 4.6 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
2.3 | 9.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
2.3 | 18.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.3 | 4.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.3 | 6.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.3 | 13.5 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
2.3 | 29.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
2.2 | 4.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
2.2 | 2.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.2 | 4.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.2 | 2.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
2.2 | 4.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.2 | 30.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.2 | 6.6 | GO:0015888 | thiamine transport(GO:0015888) |
2.2 | 13.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.2 | 6.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
2.2 | 8.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.1 | 6.4 | GO:0032252 | secretory granule localization(GO:0032252) |
2.1 | 6.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
2.1 | 4.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.1 | 4.2 | GO:0051182 | coenzyme transport(GO:0051182) |
2.1 | 2.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
2.1 | 2.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
2.1 | 2.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.1 | 12.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.1 | 2.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
2.1 | 6.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.0 | 4.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.0 | 2.0 | GO:0048242 | epinephrine secretion(GO:0048242) |
2.0 | 8.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
2.0 | 22.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.0 | 14.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
2.0 | 6.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
2.0 | 8.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.0 | 2.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.0 | 6.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.0 | 4.0 | GO:0019230 | proprioception(GO:0019230) |
2.0 | 11.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.0 | 5.9 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
2.0 | 27.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
2.0 | 9.8 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
2.0 | 25.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.9 | 15.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.9 | 15.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.9 | 5.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.9 | 5.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.9 | 5.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.9 | 5.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.9 | 28.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.9 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
1.9 | 13.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.9 | 5.6 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.9 | 5.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.9 | 13.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.8 | 1.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.8 | 5.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.8 | 5.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.8 | 20.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.8 | 14.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
1.8 | 21.8 | GO:0045056 | transcytosis(GO:0045056) |
1.8 | 7.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.8 | 9.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
1.8 | 1.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.8 | 3.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.8 | 8.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.8 | 1.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.8 | 91.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.8 | 15.8 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
1.8 | 5.3 | GO:0090427 | activation of meiosis(GO:0090427) |
1.7 | 5.2 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.7 | 6.9 | GO:0070295 | renal water absorption(GO:0070295) |
1.7 | 5.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.7 | 5.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.7 | 1.7 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.7 | 5.1 | GO:0060214 | endocardium formation(GO:0060214) |
1.7 | 27.3 | GO:0032402 | melanosome transport(GO:0032402) |
1.7 | 5.1 | GO:0036233 | glycine import(GO:0036233) |
1.7 | 6.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.7 | 15.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
1.7 | 1.7 | GO:0100012 | regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
1.7 | 3.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.7 | 5.0 | GO:0006562 | proline catabolic process(GO:0006562) |
1.7 | 3.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.7 | 6.6 | GO:0072044 | collecting duct development(GO:0072044) |
1.7 | 3.3 | GO:0061055 | myotome development(GO:0061055) |
1.6 | 8.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.6 | 6.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.6 | 8.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.6 | 4.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.6 | 4.9 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.6 | 6.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.6 | 9.8 | GO:0097264 | self proteolysis(GO:0097264) |
1.6 | 26.0 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
1.6 | 4.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.6 | 6.4 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.6 | 1.6 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
1.6 | 1.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.6 | 6.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.6 | 8.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.6 | 9.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.6 | 3.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.6 | 4.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.6 | 6.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.6 | 3.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.6 | 4.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.6 | 3.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.5 | 4.6 | GO:0060174 | limb bud formation(GO:0060174) |
1.5 | 4.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.5 | 1.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.5 | 6.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.5 | 1.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.5 | 4.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.5 | 4.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.5 | 4.5 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.5 | 4.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.5 | 17.7 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
1.5 | 2.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.5 | 10.3 | GO:0060736 | prostate gland growth(GO:0060736) |
1.5 | 4.4 | GO:0034650 | cortisol metabolic process(GO:0034650) |
1.5 | 64.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.4 | 2.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.4 | 12.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.4 | 7.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.4 | 11.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.4 | 1.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.4 | 11.3 | GO:0050957 | equilibrioception(GO:0050957) |
1.4 | 4.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.4 | 8.5 | GO:0015824 | proline transport(GO:0015824) |
1.4 | 4.2 | GO:0071435 | potassium ion export(GO:0071435) |
1.4 | 11.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
1.4 | 1.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.4 | 7.0 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.4 | 4.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.4 | 2.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.4 | 2.8 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
1.4 | 5.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.4 | 15.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
1.4 | 1.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.4 | 1.4 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.4 | 23.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.4 | 5.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.3 | 2.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.3 | 9.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.3 | 4.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 4.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.3 | 4.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.3 | 15.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.3 | 1.3 | GO:0002339 | B cell selection(GO:0002339) |
1.3 | 2.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.3 | 6.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.3 | 3.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.3 | 3.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.3 | 2.6 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.3 | 2.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.3 | 12.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.3 | 7.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.3 | 2.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.3 | 3.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.3 | 3.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.3 | 1.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
1.3 | 2.5 | GO:0051409 | response to nitrosative stress(GO:0051409) cellular response to nitrosative stress(GO:0071500) |
1.3 | 14.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.3 | 6.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
1.3 | 3.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.3 | 5.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.2 | 3.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.2 | 2.5 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
1.2 | 7.4 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
1.2 | 2.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.2 | 2.5 | GO:0038089 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.2 | 1.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.2 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.2 | 6.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.2 | 2.4 | GO:0043366 | beta selection(GO:0043366) |
1.2 | 12.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.2 | 1.2 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.2 | 3.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.2 | 3.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.2 | 3.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.2 | 2.4 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.2 | 7.1 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
1.2 | 3.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 7.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.2 | 3.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.2 | 3.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.1 | 3.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.1 | 2.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.1 | 3.4 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
1.1 | 7.9 | GO:0001964 | startle response(GO:0001964) |
1.1 | 5.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.1 | 1.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.1 | 4.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.1 | 2.2 | GO:0001555 | oocyte growth(GO:0001555) |
1.1 | 8.9 | GO:0008038 | neuron recognition(GO:0008038) |
1.1 | 7.8 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.1 | 25.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
1.1 | 13.2 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
1.1 | 5.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.1 | 19.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
1.1 | 2.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.1 | 3.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.1 | 1.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
1.1 | 3.3 | GO:0036035 | osteoclast development(GO:0036035) |
1.1 | 1.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.1 | 2.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.1 | 2.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.1 | 5.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.1 | 3.2 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.1 | 13.8 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
1.1 | 3.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 3.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.1 | 5.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.1 | 2.1 | GO:0072033 | renal vesicle formation(GO:0072033) ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.1 | 1.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.0 | 2.1 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 3.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.0 | 4.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.0 | 8.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.0 | 4.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
1.0 | 6.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
1.0 | 4.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.0 | 3.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
1.0 | 3.1 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.0 | 2.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.0 | 5.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.0 | 2.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 3.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.0 | 3.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
1.0 | 5.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.0 | 64.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 50.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
1.0 | 1.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.0 | 35.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.0 | 1.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.0 | 7.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.0 | 2.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.0 | 2.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.0 | 2.9 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
1.0 | 2.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.0 | 2.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.0 | 2.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.0 | 1.0 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
1.0 | 4.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.0 | 1.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.0 | 2.9 | GO:0090383 | phagosome acidification(GO:0090383) |
1.0 | 1.9 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.9 | 7.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.9 | 2.8 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 1.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.9 | 0.9 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 4.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.9 | 1.9 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.9 | 2.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 4.7 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.9 | 13.9 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.9 | 4.6 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.9 | 2.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.9 | 0.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.9 | 0.9 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.9 | 0.9 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.9 | 2.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.9 | 2.8 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.9 | 1.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.9 | 4.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.9 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 3.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.9 | 0.9 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.9 | 3.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 3.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.9 | 4.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.9 | 3.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.9 | 4.4 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.9 | 0.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.9 | 0.9 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.9 | 2.6 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 2.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 3.5 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.9 | 37.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.9 | 0.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.9 | 0.9 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.9 | 1.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 0.9 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.9 | 0.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.9 | 3.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.8 | 1.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.8 | 1.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.8 | 2.5 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 0.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.8 | 5.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.8 | 4.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.8 | 1.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 1.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.8 | 2.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.8 | 3.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.8 | 3.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.8 | 5.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.8 | 1.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.8 | 28.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.8 | 3.2 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.8 | 3.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.8 | 4.0 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.8 | 8.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.8 | 4.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.8 | 2.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.8 | 1.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.8 | 2.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.8 | 2.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.8 | 3.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.8 | 15.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.8 | 1.6 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.8 | 2.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.8 | 2.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.8 | 2.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.8 | 1.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.8 | 4.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.8 | 2.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.8 | 3.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 2.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.8 | 2.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.8 | 3.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.8 | 2.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.8 | 9.0 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.8 | 15.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.8 | 3.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.8 | 3.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.7 | 2.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.7 | 1.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.7 | 11.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.7 | 3.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.7 | 0.7 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.7 | 2.9 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.7 | 0.7 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.7 | 8.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.7 | 43.2 | GO:0007612 | learning(GO:0007612) |
0.7 | 2.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.7 | 5.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.7 | 2.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.7 | 9.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.7 | 4.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.7 | 12.9 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.7 | 3.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 3.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.7 | 2.8 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 1.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.7 | 2.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.7 | 4.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 5.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.7 | 2.8 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.7 | 2.8 | GO:0060242 | contact inhibition(GO:0060242) |
0.7 | 3.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.7 | 1.4 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.7 | 0.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.7 | 2.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.7 | 0.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.7 | 1.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.7 | 2.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.7 | 1.4 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.7 | 3.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.7 | 1.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.7 | 1.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.7 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.7 | 9.5 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.7 | 0.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.7 | 4.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.7 | 49.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.7 | 23.8 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.7 | 4.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.7 | 2.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 2.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.7 | 2.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.7 | 0.7 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.7 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 | 1.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.7 | 2.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.6 | 1.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.6 | 21.4 | GO:0006813 | potassium ion transport(GO:0006813) |
0.6 | 0.6 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.6 | 1.3 | GO:0060740 | prostate gland epithelium morphogenesis(GO:0060740) |
0.6 | 5.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.6 | 2.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 1.9 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.6 | 3.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.6 | 18.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.6 | 6.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.6 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 3.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.6 | 2.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.6 | 1.2 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 8.1 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.6 | 2.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.6 | 1.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.6 | 1.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.6 | 1.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 1.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.6 | 0.6 | GO:1902965 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.6 | 2.5 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 1.8 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.6 | 1.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.6 | 4.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.6 | 1.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 4.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.6 | 4.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 0.6 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.6 | 4.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 0.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.6 | 2.4 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.6 | 4.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.6 | 1.8 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 0.6 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.6 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 1.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 1.1 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.6 | 0.6 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.6 | 4.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 1.1 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.6 | 1.7 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 3.4 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.6 | 1.1 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.6 | 9.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.6 | 0.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.6 | 1.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 1.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 1.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.5 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.5 | 2.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 4.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.5 | 2.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 2.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 3.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 3.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.5 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 3.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.5 | 7.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.5 | 1.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.5 | 5.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.5 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 3.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.5 | 4.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.5 | 2.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.5 | 1.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.5 | 2.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 0.5 | GO:0060459 | left lung development(GO:0060459) |
0.5 | 1.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.5 | 1.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.5 | 1.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.5 | 0.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.5 | 1.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 8.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 0.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.5 | 4.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.5 | 8.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.5 | 1.0 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 1.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.5 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 5.6 | GO:0030901 | midbrain development(GO:0030901) |
0.5 | 3.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.5 | 1.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 1.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.5 | 1.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.5 | 0.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.5 | 1.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 3.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 2.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 0.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 0.5 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.4 | 5.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 0.4 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.4 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 0.9 | GO:0007567 | parturition(GO:0007567) |
0.4 | 1.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 2.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.4 | 0.9 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.4 | 0.8 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.4 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 0.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 1.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.4 | 2.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 1.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 0.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 4.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.2 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.4 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 7.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 0.4 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.4 | 10.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.4 | 1.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 2.7 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 3.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 1.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 1.1 | GO:0070268 | cornification(GO:0070268) |
0.4 | 1.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.4 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 1.9 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 1.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.4 | 9.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 3.0 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 0.4 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.4 | 0.4 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.4 | 4.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.4 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 0.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 1.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 0.7 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 0.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 2.5 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 2.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.4 | 1.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 8.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 1.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.4 | 1.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.8 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.4 | 4.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.4 | 0.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 1.4 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.3 | 0.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 0.7 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 19.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.3 | 1.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 2.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 0.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 1.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 0.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.3 | 0.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 1.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 0.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 0.9 | GO:0070649 | parallel actin filament bundle assembly(GO:0030046) polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 0.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.3 | 2.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 5.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 1.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 0.3 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 1.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 4.5 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.3 | 0.9 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 0.3 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 0.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 0.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.8 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 0.3 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.3 | 2.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.6 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 0.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.3 | 0.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.3 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.3 | 1.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.3 | 0.3 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 1.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 3.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 5.9 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.3 | 2.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 0.8 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.3 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.3 | 2.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.5 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.3 | 0.8 | GO:0098868 | bone growth(GO:0098868) |
0.3 | 0.3 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.2 | 1.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 3.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 1.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 3.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.2 | 1.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 | 1.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.7 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 6.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.2 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.9 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.2 | 0.9 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 1.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 4.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.3 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 2.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 0.7 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.2 | 2.6 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 1.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 3.5 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.2 | 3.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.4 | GO:0015810 | aspartate transport(GO:0015810) |
0.2 | 2.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 0.6 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 1.5 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.2 | 1.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.2 | 0.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.4 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.2 | 0.4 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.2 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.9 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 0.2 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.2 | 0.4 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 0.4 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.4 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 3.5 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.2 | 0.2 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 6.9 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.2 | 2.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.2 | 1.0 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 2.4 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.2 | 1.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.8 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.2 | 0.6 | GO:0046110 | purine nucleobase catabolic process(GO:0006145) xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.2 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 1.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 0.5 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 2.8 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.1 | 0.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 1.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.1 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 1.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 4.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.7 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.4 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.9 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.4 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 2.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 1.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 4.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.4 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.4 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 2.5 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 1.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
0.1 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.4 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.4 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 4.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 1.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.2 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.1 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 54.4 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.0 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.2 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.0 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.0 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.0 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.0 | 0.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.0 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.0 | 0.0 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.9 | 107.5 | GO:0036156 | inner dynein arm(GO:0036156) |
7.6 | 22.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
7.4 | 22.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
6.5 | 6.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
6.4 | 57.2 | GO:0005883 | neurofilament(GO:0005883) |
4.9 | 49.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
4.6 | 55.8 | GO:0043194 | axon initial segment(GO:0043194) |
4.5 | 31.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
4.5 | 18.0 | GO:0044308 | axonal spine(GO:0044308) |
4.3 | 17.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
4.1 | 12.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
4.1 | 12.2 | GO:0071942 | XPC complex(GO:0071942) |
3.9 | 19.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
3.9 | 23.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
3.8 | 19.0 | GO:0033503 | HULC complex(GO:0033503) |
3.7 | 3.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.5 | 24.8 | GO:0033263 | CORVET complex(GO:0033263) |
3.5 | 10.5 | GO:0097427 | microtubule bundle(GO:0097427) |
3.4 | 13.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
3.3 | 43.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
3.2 | 25.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
3.1 | 24.6 | GO:0043083 | synaptic cleft(GO:0043083) |
3.1 | 9.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.0 | 27.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
3.0 | 54.4 | GO:0030673 | axolemma(GO:0030673) |
3.0 | 27.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
2.9 | 11.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.9 | 11.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.8 | 56.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.8 | 22.2 | GO:0005858 | axonemal dynein complex(GO:0005858) outer dynein arm(GO:0036157) |
2.8 | 24.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
2.7 | 13.7 | GO:0033268 | node of Ranvier(GO:0033268) |
2.7 | 24.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.7 | 13.5 | GO:0005579 | membrane attack complex(GO:0005579) |
2.7 | 8.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
2.6 | 36.6 | GO:0031430 | M band(GO:0031430) |
2.6 | 23.3 | GO:0005869 | dynactin complex(GO:0005869) |
2.6 | 10.2 | GO:0005955 | calcineurin complex(GO:0005955) |
2.5 | 9.9 | GO:1990130 | Iml1 complex(GO:1990130) |
2.5 | 14.8 | GO:0002177 | manchette(GO:0002177) |
2.4 | 7.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
2.4 | 7.3 | GO:0033010 | paranodal junction(GO:0033010) |
2.3 | 14.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
2.3 | 16.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.3 | 29.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.1 | 10.6 | GO:0097433 | dense body(GO:0097433) |
2.1 | 120.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
2.0 | 8.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.0 | 6.1 | GO:1990357 | terminal web(GO:1990357) |
2.0 | 7.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.9 | 26.6 | GO:0071565 | nBAF complex(GO:0071565) |
1.9 | 9.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.8 | 11.0 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.7 | 5.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.7 | 6.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.7 | 5.1 | GO:0071564 | npBAF complex(GO:0071564) |
1.7 | 30.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.6 | 3.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.6 | 6.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.6 | 12.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.5 | 15.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.5 | 31.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.5 | 19.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
1.5 | 6.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.5 | 3.0 | GO:0098984 | symmetric synapse(GO:0032280) neuron to neuron synapse(GO:0098984) |
1.5 | 5.8 | GO:1990246 | uniplex complex(GO:1990246) |
1.5 | 4.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.4 | 8.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.4 | 14.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.4 | 7.1 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.4 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.4 | 6.9 | GO:0034464 | BBSome(GO:0034464) |
1.3 | 15.8 | GO:0032426 | stereocilium tip(GO:0032426) |
1.2 | 8.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.2 | 9.5 | GO:0042587 | glycogen granule(GO:0042587) |
1.2 | 9.3 | GO:0044447 | axoneme part(GO:0044447) |
1.2 | 3.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.1 | 8.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.1 | 17.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.1 | 3.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.1 | 5.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.1 | 10.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
1.1 | 9.0 | GO:0032590 | dendrite membrane(GO:0032590) |
1.1 | 15.6 | GO:0043196 | varicosity(GO:0043196) |
1.1 | 3.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.1 | 4.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.0 | 8.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.0 | 4.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.0 | 3.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 1.0 | GO:0044299 | C-fiber(GO:0044299) |
1.0 | 4.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.0 | 2.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.0 | 6.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 1.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.0 | 4.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.9 | 2.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 8.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.9 | 6.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 24.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 6.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 5.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 10.4 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 5.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.8 | 75.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.8 | 2.5 | GO:0042827 | platelet dense granule(GO:0042827) |
0.8 | 2.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 11.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.8 | 2.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 32.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.8 | 108.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 4.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 2.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.8 | 7.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.8 | 1.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.8 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.8 | 1.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.7 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 3.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.7 | 2.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.7 | 2.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 7.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.7 | 8.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.7 | 4.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.7 | 2.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 2.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 12.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.6 | 2.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 6.8 | GO:0001741 | XY body(GO:0001741) |
0.6 | 5.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 10.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 86.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 1.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 5.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 5.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.6 | 4.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 2.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 1.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 1.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 6.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 2.2 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 2.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 0.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 6.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 5.7 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 1.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.5 | 1.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 2.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.5 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 0.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 3.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 1.4 | GO:0008091 | spectrin(GO:0008091) |
0.4 | 1.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 7.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 3.0 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 1.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 1.2 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 1.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.4 | 3.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 37.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.4 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 5.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 3.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.4 | 1.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.4 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 5.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 0.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 1.0 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 22.0 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 2.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.3 | 4.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 7.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 0.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 0.9 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 1.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 15.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 1.7 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 1.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 7.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 2.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 13.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 222.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.2 | 3.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 2.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 3.1 | GO:0043205 | fibril(GO:0043205) |
0.2 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 1.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 5.7 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 8.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.8 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 1.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.2 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 3.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 2.0 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 1.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 1.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 2.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 3.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 3.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 1.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 3.7 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.2 | 66.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
9.7 | 48.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
9.7 | 48.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
9.2 | 36.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
7.7 | 23.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
7.6 | 22.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.9 | 20.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.7 | 47.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
6.6 | 26.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
6.4 | 12.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
6.0 | 23.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
5.6 | 28.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
5.6 | 50.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
5.6 | 11.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
5.5 | 16.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
5.5 | 16.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.2 | 26.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
5.2 | 15.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
5.0 | 15.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
5.0 | 30.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.9 | 14.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.7 | 28.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.6 | 13.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
4.3 | 4.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
4.3 | 21.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
4.1 | 12.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.9 | 42.6 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
3.9 | 11.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
3.7 | 11.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.7 | 29.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
3.6 | 10.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
3.6 | 25.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
3.5 | 53.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
3.5 | 10.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.4 | 20.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
3.2 | 9.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
3.2 | 16.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.2 | 9.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
3.2 | 3.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
3.2 | 44.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
3.0 | 12.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.0 | 14.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
2.9 | 17.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
2.8 | 8.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.8 | 11.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.8 | 8.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.8 | 8.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.8 | 8.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
2.8 | 88.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.8 | 11.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.7 | 16.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.7 | 13.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.7 | 37.8 | GO:0031402 | sodium ion binding(GO:0031402) |
2.7 | 8.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
2.7 | 37.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.6 | 2.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.5 | 7.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.5 | 7.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.4 | 4.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.4 | 9.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.4 | 7.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
2.2 | 6.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.2 | 29.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.2 | 8.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.2 | 8.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.2 | 74.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
2.2 | 17.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
2.1 | 6.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.1 | 46.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
2.1 | 8.3 | GO:0070052 | collagen V binding(GO:0070052) |
2.0 | 12.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
2.0 | 14.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.0 | 13.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
2.0 | 5.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
2.0 | 5.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.9 | 3.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.9 | 31.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.9 | 15.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.9 | 55.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.9 | 21.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.9 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.8 | 5.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.8 | 9.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.8 | 5.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.8 | 96.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.7 | 3.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.7 | 6.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.7 | 20.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.7 | 5.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
1.7 | 30.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.7 | 47.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.7 | 15.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.7 | 1.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.7 | 30.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.7 | 3.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.7 | 28.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.6 | 4.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.6 | 35.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
1.6 | 8.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.6 | 4.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.6 | 8.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.6 | 6.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.6 | 4.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.6 | 7.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.6 | 4.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.5 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.5 | 9.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.5 | 6.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.5 | 6.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.5 | 22.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
1.5 | 7.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.5 | 5.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.4 | 8.7 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.4 | 8.7 | GO:0002054 | nucleobase binding(GO:0002054) |
1.4 | 2.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.4 | 8.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.4 | 5.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.4 | 7.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.4 | 5.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.4 | 2.8 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.4 | 6.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.4 | 4.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.3 | 2.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 6.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.3 | 5.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.3 | 14.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.3 | 2.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.3 | 9.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 7.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.3 | 5.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.3 | 16.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.3 | 3.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.3 | 7.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.2 | 35.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.2 | 3.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.2 | 4.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.2 | 4.8 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 14.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.2 | 3.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.2 | 27.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.2 | 3.5 | GO:0048030 | disaccharide binding(GO:0048030) |
1.1 | 18.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
1.1 | 51.5 | GO:0030276 | clathrin binding(GO:0030276) |
1.1 | 3.4 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.1 | 4.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.1 | 4.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.1 | 3.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.1 | 16.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.1 | 15.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 7.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.1 | 45.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
1.1 | 31.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
1.0 | 10.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.0 | 11.5 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 3.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.0 | 5.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 3.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.0 | 10.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.0 | 4.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.0 | 9.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.0 | 4.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.0 | 23.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.0 | 5.0 | GO:0016151 | nickel cation binding(GO:0016151) |
1.0 | 3.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.0 | 3.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.0 | 3.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.0 | 25.7 | GO:0045502 | dynein binding(GO:0045502) |
1.0 | 3.8 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.9 | 4.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 8.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.9 | 2.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.9 | 2.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.9 | 6.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.9 | 4.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.9 | 4.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 4.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.9 | 18.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.9 | 12.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.9 | 3.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.9 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 4.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.9 | 17.4 | GO:0005537 | mannose binding(GO:0005537) |
0.9 | 0.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 3.4 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.9 | 1.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.9 | 5.1 | GO:0015288 | porin activity(GO:0015288) |
0.8 | 12.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 1.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 3.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.8 | 12.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.8 | 2.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.8 | 5.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.8 | 5.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.8 | 20.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 13.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.8 | 32.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.8 | 3.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 10.4 | GO:0071949 | FAD binding(GO:0071949) |
0.8 | 2.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.8 | 2.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 1.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.8 | 10.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.8 | 3.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.8 | 6.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.8 | 5.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.8 | 3.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 7.6 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.8 | 11.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.8 | 12.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 5.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 8.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 1.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 3.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.7 | 15.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.7 | 8.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.7 | 2.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 4.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 4.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.7 | 3.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.7 | 5.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.7 | 2.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 2.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.7 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 2.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 2.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 2.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.7 | 2.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.6 | 20.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 8.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 3.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 3.8 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.6 | 1.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.6 | 2.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.6 | 6.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 2.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.6 | 4.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 1.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 2.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.6 | 1.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.6 | 3.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 3.0 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.6 | 1.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.6 | 7.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.6 | 8.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 2.9 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.6 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.6 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.6 | 5.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 33.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.6 | 3.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 13.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.5 | 0.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.5 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 5.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.5 | 1.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 5.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 2.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 2.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 2.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 2.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 2.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 6.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 8.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 3.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.5 | 2.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 1.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.5 | 2.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 1.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.5 | 3.0 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 8.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.5 | 20.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 12.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 8.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 2.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 2.8 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.5 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 0.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.5 | 3.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 20.2 | GO:0051287 | NAD binding(GO:0051287) |
0.4 | 9.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 6.7 | GO:0052769 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.4 | 4.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.4 | 3.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 15.1 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 1.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 2.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 6.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 1.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 4.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 2.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.4 | 3.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.4 | 1.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 2.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) TFIID-class transcription factor binding(GO:0001094) |
0.4 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 1.9 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.4 | 7.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 1.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.7 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.3 | 3.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 2.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.3 | 0.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 2.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 2.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 2.8 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 1.6 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 1.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 1.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 1.2 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 6.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.3 | 1.5 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 3.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 0.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 4.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 3.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 1.4 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 2.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 4.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 0.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 4.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 109.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 2.4 | GO:0034876 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.3 | 6.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 45.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.7 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 2.0 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 4.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.8 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.2 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 3.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 3.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 1.6 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.2 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 6.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.4 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.2 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 2.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 13.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 1.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 15.5 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 3.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 9.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 3.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 3.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 50.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.4 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.1 | 0.9 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0018588 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 16.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 26.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 1.2 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.2 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.2 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 106.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.3 | 50.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
3.0 | 142.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
2.6 | 23.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.4 | 21.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
2.3 | 14.0 | ST ADRENERGIC | Adrenergic Pathway |
2.2 | 57.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
2.0 | 47.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.9 | 21.2 | PID ALK2 PATHWAY | ALK2 signaling events |
1.8 | 26.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.7 | 45.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.6 | 40.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.6 | 14.1 | ST GAQ PATHWAY | G alpha q Pathway |
1.5 | 13.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 15.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.4 | 18.0 | PID REELIN PATHWAY | Reelin signaling pathway |
1.3 | 18.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.3 | 30.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.2 | 27.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.2 | 2.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.2 | 26.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.2 | 18.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 1.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 12.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 15.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.0 | 14.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.0 | 7.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 15.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 4.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 23.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 14.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.8 | 13.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.8 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.7 | 3.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.7 | 16.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.6 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 3.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 5.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 6.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 1.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 3.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 1.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 3.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 11.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 2.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 1.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 3.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 5.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 7.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 47.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 6.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 3.8 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 5.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 6.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 2.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 15.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 8.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 20.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
5.2 | 78.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
4.1 | 44.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.6 | 50.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
3.5 | 55.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
3.3 | 39.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
3.2 | 9.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.1 | 9.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.9 | 11.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.8 | 5.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
2.8 | 2.8 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
2.7 | 38.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.7 | 56.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.6 | 5.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
2.5 | 35.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.3 | 92.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.3 | 24.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
2.1 | 4.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
1.9 | 20.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.8 | 27.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.8 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.7 | 69.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.7 | 1.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.7 | 13.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.6 | 3.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.6 | 22.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.6 | 15.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.5 | 20.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.3 | 21.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.3 | 14.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.3 | 35.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.3 | 21.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.3 | 24.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 16.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
1.2 | 39.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.2 | 6.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.2 | 4.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.2 | 12.1 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
1.0 | 10.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.0 | 8.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 9.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.0 | 18.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.9 | 12.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 0.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.9 | 1.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.9 | 7.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 12.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.9 | 11.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.9 | 7.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 5.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.8 | 21.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.8 | 9.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.8 | 19.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 4.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 18.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.7 | 4.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.7 | 1.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.7 | 13.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 7.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.7 | 2.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 5.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 2.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 4.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 11.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.6 | 8.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 4.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 9.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 6.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 4.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.5 | 12.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 2.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.5 | 7.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 2.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 8.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.5 | 4.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 19.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.5 | 8.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 9.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 71.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.5 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 10.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 8.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 7.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 5.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 7.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 11.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 4.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 8.3 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.4 | 2.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 0.4 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.4 | 4.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 5.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 8.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 2.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 2.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 0.7 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 12.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.3 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 2.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 19.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.3 | 3.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 11.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 4.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 3.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 5.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 3.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 0.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 1.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 4.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 11.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 9.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 15.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 7.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 3.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 2.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 4.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 5.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 3.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.2 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.9 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 1.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |